Globus Medical Inc (GMED) Stock Analysis
Verdict: BUY
Integration synergies and robotic platform pull-through are driving massive earnings beats, making the recent ~24% pullback a value entry.
Investment score: 72/100
Analysis as of
Is Globus Medical Inc stock worth reviewing? AI model thesis
GMED is a high-margin musculoskeletal leader trading at a discount to historical norms and peers after a technical correction. Strong earnings momentum and a healthy balance sheet offset the lack of insider buying.
7-factor investment score
- Valuation: 65/100 (weight 20%)
- Financial Health: 85/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 90/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 88/100 (weight 10%)
- Risk-Adjusted Return: 75/100 (weight 15%)
Globus Medical Inc opportunities and risks
What speaks for GMED
- Post-Merger Synergy Acceleration
What speaks against GMED
- Sales Force Attrition and Disruption
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| GMED | 17.8x | 3.4x | 11.4x | 67.9% | 18.9% | 5.8% |
| ZBH | 21.9x | 1.9x | 10.6x | 70.0% | 9.1% | 11.2% |
| PEN | 72.1x | 8.5x | 56.1x | 67.4% | 11.8% | 1.7% |
| BAX | n/a | 1.0x | 25.3x | 30.1% | -9.7% | 6.5% |
| PODD | 35.5x | 3.7x | 19.2x | 71.0% | 10.4% | 3.9% |
| GKOS | n/a | 14.8x | n/a | 78.1% | -34.3% | -0.2% |
| Peer median | 21.9x | 3.7x | 19.2x | 70.0% | 9.1% | 3.9% |
Frequently asked questions about Globus Medical Inc (GMED)
Is GMED stock a good investment?
The cached TradeMates AI model rates Globus Medical Inc as BUY with an investment score of 72/100. GMED is a high-margin musculoskeletal leader trading at a discount to historical norms and peers after a technical correction. Strong earnings momentum and a healthy balance sheet offset the lack of insider buying. This is algorithmic model output, not personal investment advice.
Is GMED stock a buy?
The TradeMates model verdict for GMED is BUY with an investment score of 72/100. Treat this as a model signal to review, not a personal buy recommendation.